| Study name |
The effectiveness of light therapy on sleep quality, cognitive function, BPSD, and depression in patients with mild cognitive impairment and dementia: a randomized controlled trial |
| Methods |
Randomised controlled trial |
| Participants |
Inclusion criteria:
simple MMSE ≥ 24 points or MoCA cut score 23/24 is divided into mild cognitive dysfunction, or meet the ICD‐10 mild and moderate dementia diagnosis can communicate in Mandarin (Taiwan) aged > 65 years complaints of sleep disorders, and PSQI ≥ 5 points regular and stable medication no special eye disease, can accept continuous light living in an institution, the staff can monitor their sleep status, or their coresident family members can assist in monitoring their sleep status must have signed an informed consent form themselves or their family members.
Exclusion criteria:
any primary neurological disease that affects the quality of sleep, such as narcolepsy or sleep cessation syndrome diagnosed by a physician with obvious mental illness or communication disorders assessed by the sleep apnoea scale in the Sleep Disorders Questionnaire, females > 26 points, males > 29 points, judged to have sleep apnoea photosensitivity dermatitis in the past diagnosed by a physician with related eye diseases that cannot receive continuously light unsuitable to participate in this course of treatment after being assessed by a physician
Aged: 65–100 years
Gender: both |
| Interventions |
Intervention: light therapy
Control: standard light group |
| Outcomes |
Sleep quality; cognitive function; behavioural and psychological symptom associated with dementia, BPSD; depression |
| Starting date |
8 February 2020 |
| Contact information |
kueiru@tmu.edu.tw |
| Notes |
Authors did not respond after several contact attempts. |
